Announcements
- 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing
- 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance
- 10X Capital Venture Acquisition Corp. III Announces Expected Change in Management
- 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q Filing
- 10X Capital Venture Acquisition Corp. III Announces Transfer of Listed Securities to the NYSE American
- Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III
More ▼
Key statistics
As of last trade 10X Capital Venture Acquisition Corp III (VCXB:ASQ) traded at 10.98, -0.18% below its 52-week high of 11.00, set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.98 |
---|---|
High | 10.98 |
Low | 10.98 |
Bid | 10.96 |
Offer | 10.98 |
Previous close | 10.98 |
Average volume | 860.00 |
---|---|
Shares outstanding | 13.19m |
Free float | 13.19m |
P/E (TTM) | -- |
Market cap | 144.87m USD |
EPS (TTM) | -0.0842 USD |
Data delayed at least 15 minutes, as of May 22 2024 21:10 BST.
More ▼